Literature DB >> 18095079

Levels and expressions of orotate phosphoribosyltransferase in gastric carcinoma and normal gastric mucosa tissues.

Yoichi Sakurai1, Shingo Kamoshida, Shinpei Furuta, Risaburo Sunagawa, Kazuki Inaba, Jun Isogaki, Yoshiyuki Komori, Ichiro Uyama, Yutaka Tsutsumi.   

Abstract

BACKGROUND: Orotate phosphoribosyltransferase (OPRT; EC 2.4.2.10), a key enzyme that catalyzes one of the primary steps in the phosphorylation of fluoropyrimidine, was recently recognized as an important enzyme that determines the anticancer effects of the dihydropyrimidine dehydrogenase-inhibitory fluoropyrimidine, S-1.
METHODS: Levels of OPRT were examined in 97 gastric carcinoma tissues and 65 normal gastric mucosa tissues obtained from patients with gastric carcinoma. The relation between OPRT levels and clinicopathological variables was evaluated, and correlations of OPRT with thymidylate synthase and dihydropyrimidine dehydrogenase levels in gastric carcinoma tissues were evaluated.
RESULTS: Although OPRT levels were high in well-differentiated and localized carcinomas, they were not correlated with other clinicopathological variables or with the pathological stage of gastric carcinoma. Levels of OPRT were significantly higher in gastric carcinoma tissue than in normal gastric mucosa. OPRT levels were not correlated with levels of either thymidylate synthase or dihydropyrimidine dehydrogenase. In samples of gastric carcinoma tissues and normal gastric mucosa tissues obtained simultaneously from 24 patients, no correlation was found between OPRT levels in gastric carcinoma and levels in normal gastric mucosa.
CONCLUSION: These results suggest that the OPRT level is significantly higher in gastric carcinoma tissue than in normal gastric mucosa and that the OPRT level in gastric carcinoma is a novel variable that is independent of the levels of other previously known enzymes related to 5-fluorouracil (FU) metabolism.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18095079     DOI: 10.1007/s10120-007-0440-9

Source DB:  PubMed          Journal:  Gastric Cancer        ISSN: 1436-3291            Impact factor:   7.370


  24 in total

1.  Impact of orotate phosphoribosyl transferase activity as a predictor of lymph node metastasis in gastric cancer.

Authors:  Takumi Ochiai; Michiharu Sugitani; Kazuhiko Nishimura; Hajime Noguchi; Tsuyoshi Okada; Masakazu Ouchi; Masaki Yamada; Masayuki Kitajima; Yuko Tsuruoka; Yuka Takahashi; Shunji Futagawa
Journal:  Oncol Rep       Date:  2005-10       Impact factor: 3.906

2.  Development of a novel form of an oral 5-fluorouracil derivative (S-1) directed to the potentiation of the tumor selective cytotoxicity of 5-fluorouracil by two biochemical modulators.

Authors:  T Shirasaka; Y Shimamato; H Ohshimo; M Yamaguchi; T Kato; K Yonekura; M Fukushima
Journal:  Anticancer Drugs       Date:  1996-07       Impact factor: 2.248

3.  The analysis of the innate pathways of 5-fluorouracil phosphorylation in human gastrointestinal cancer cell lines in vitro and in vivo.

Authors:  M Fukushima; Y Murakami; N Suzuki; K Aiba
Journal:  Oncol Rep       Date:  1997 Nov-Dec       Impact factor: 3.906

4.  [Preparation of anti-OPRT antibody for immunochemical detection].

Authors:  Kazuki Sakamoto; Yoshikazu Sugimoto; Kazutaka Miyadera; Toshinori Oka; Masakazu Fukushima
Journal:  Gan To Kagaku Ryoho       Date:  2005-05

Review 5.  S-1 in gastric cancer: a comprehensive review.

Authors:  Yoshihiko Maehara
Journal:  Gastric Cancer       Date:  2003       Impact factor: 7.370

6.  Sensitivity of human, murine, and rat cells to 5-fluorouracil and 5'-deoxy-5-fluorouridine in relation to drug-metabolizing enzymes.

Authors:  G J Peters; E Laurensse; A Leyva; J Lankelma; H M Pinedo
Journal:  Cancer Res       Date:  1986-01       Impact factor: 12.701

7.  Molecular cloning and nucleotide sequence for the complete coding region of human UMP synthase.

Authors:  D P Suttle; B Y Bugg; J K Winkler; J J Kanalas
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

8.  Prognostic significance of orotate phosphoribosyltransferase activity in bladder carcinoma.

Authors:  Yoichi Mizutani; Hiromi Wada; Masakazu Fukushima; Osamu Yoshida; Hiroyuki Nakanishi; Yong Nan Li; Tsuneharu Miki
Journal:  Cancer       Date:  2004-02-15       Impact factor: 6.860

9.  Pathology and prognosis of gastric carcinoma. Findings in 10,000 patients who underwent primary gastrectomy.

Authors:  K Nakamura; T Ueyama; T Yao; Z X Xuan; K Ambe; Y Adachi; Y Yakeishi; A Matsukuma; M Enjoji
Journal:  Cancer       Date:  1992-09-01       Impact factor: 6.860

10.  Long-term results of surgery for early gastric cancer.

Authors:  T Popiela; J Kulig; P Kolodziejczyk; M Sierzega
Journal:  Br J Surg       Date:  2002-08       Impact factor: 6.939

View more
  1 in total

Review 1.  S-1 (Teysuno®): a review of its use in advanced gastric cancer in non-Asian populations.

Authors:  M Sanford
Journal:  Drugs       Date:  2013-06       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.